# Acumen Pharmaceuticals, Inc.: Form DEF 14A, filed Apr 23, 2026

- Company: [Acumen Pharmaceuticals, Inc.](/companies/abos.md) (CIK 1576885)
- Form: DEF 14A
- Filed: 2026-04-23
- Accepted by EDGAR: Apr 23, 2026, 16:30 ET
- Period: 2025-12-31
- Accession: 0001628280-26-026870
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1576885/000162828026026870/abos-20260423.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1576885/000162828026026870/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1576885/000162828026026870/abos-20260423.htm

Filed Apr 23, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-026870. Last ingested by Listed: Nov 5, 2026, 16:24 ET. No prices; not investment advice.